𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Breast preservation following primary chemotherapy or primary radiotherapy in large breast cancer: A randomized trial

✍ Scribed by Alain Fourquet; François Campana; Suzy S. Scholl; Bernard Asselain; Anne de la Rochefordière; Pierre Pouillart; Jacques R. Vilcoq

Publisher
Elsevier Science
Year
1993
Tongue
English
Weight
115 KB
Volume
27
Category
Article
ISSN
0360-3016

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase 2 randomized trial of primary endo
Phase 2 randomized trial of primary endocrine therapy versus chemotherapy in postmenopausal patients with estrogen receptor-positive breast cancer
✍ Vladimir F. Semiglazov; Vladislav V. Semiglazov; Garik A. Dashyan; Elena K. Zilt 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 194 KB

## Abstract ## BACKGROUND. Few studies have compared primary neoadjuvant endocrine therapy with neoadjuvant chemotherapy in breast cancer patients. The need for preoperative chemotherapy with doxorubicin or taxanes may be reduced in postmenopausal patients with estrogen receptor (ER)‐positive and/

No significant predictive value of c- er
No significant predictive value of c- erbB-2 or p53 expression regarding sensitivity to primary chemotherapy or radiotherapy in breast cancer
✍ Sylvie Rozan; Anne Vincent-Salomon; Brigitte Zafrani; Pierre Validire; Patricia 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 325 KB 👁 2 views

To document whether c-erbB-2 over-expression or p53 accumulation in tumour cells was predictive of response to chemo-or radiotherapy, we analyzed a population of patients with breast cancer assigned to neo-adjuvant therapy (median follow-up: 54 months). T2/T3-N0N1b-M0 tumours (329 cases) were treate